Literature DB >> 11009577

Behçet's disease.

V Kontogiannis1, R J Powell.   

Abstract

Behçet's disease is a systemic vasculitis of unknown aetiology characteristically affecting venules. Onset is typically in young adults with recurrent oral and genital ulceration, uveitis, skin manifestations, arthritis, neurological involvement, and a tendency to thrombosis. It has a worldwide distribution but is prevalent in Japan, the Middle East, and some Mediterranean countries. International diagnostic criteria have been proposed, however diagnosis can be problematical, particularly if the typical ulcers are not obvious at presentation. Treatment is challenging, must be tailored to the pattern of organ involvement for each patient and often requires combination therapies.

Entities:  

Mesh:

Year:  2000        PMID: 11009577      PMCID: PMC1741755          DOI: 10.1136/pmj.76.900.629

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  96 in total

1.  Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases.

Authors:  V Hamuryudan; S Yurdakul; F Moral; F Numan; H Tüzün; N Tüzüner; C Mat; Y Tüzün; Y Ozyazgan; H Yazïci
Journal:  Br J Rheumatol       Date:  1994-01

2.  Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.

Authors:  N Mizuki; H Inoko; H Ando; S Nakamura; K Kashiwase; T Akaza; Y Fujino; K Masuda; M Takiguchi; S Ohno
Journal:  Am J Ophthalmol       Date:  1993-10-15       Impact factor: 5.258

3.  Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome.

Authors:  I Fresko; H Yazici; M Bayramiçli; S Yurdakul; C Mat
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

4.  Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.

Authors:  S M Whitcup; E C Salvo; R B Nussenblatt
Journal:  Am J Ophthalmol       Date:  1994-07-15       Impact factor: 5.258

5.  Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.

Authors:  V Hamuryudan; C Mat; S Saip; Y Ozyazgan; A Siva; S Yurdakul; K Zwingenberger; H Yazici
Journal:  Ann Intern Med       Date:  1998-03-15       Impact factor: 25.391

Review 6.  Molecular genetics (HLA) of Behçet's disease.

Authors:  N Mizuki; H Inoko; S Ohno
Journal:  Yonsei Med J       Date:  1997-12       Impact factor: 2.759

Review 7.  Acute febrile neutrophilic dermatosis (Sweet's syndrome) in neuro-Behçet's disease.

Authors:  H Uysal; H Vahaboğlu; L Inan; G Vahaboğlu
Journal:  Clin Neurol Neurosurg       Date:  1993-12       Impact factor: 1.876

8.  T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.

Authors:  K Pervin; A Childerstone; T Shinnick; Y Mizushima; R van der Zee; A Hasan; R Vaughan; T Lehner
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

9.  Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.

Authors:  S Hirohata; H Suda; T Hashimoto
Journal:  J Neurol Sci       Date:  1998-08-14       Impact factor: 3.181

10.  A case of Adamantiadis-Behçet's syndrome presenting as myocardial infarction.

Authors:  D Ioakimidis; C Georganas; C Panagoulis; A Gournizakis; A Iliopoulos; D Kremastinos; T Kontomerkos
Journal:  Clin Exp Rheumatol       Date:  1993 Mar-Apr       Impact factor: 4.473

View more
  21 in total

1.  Otolaryngologic Manifestations of Various Rheumatic Diseases: Awareness and Practice Among Otolaryngologists.

Authors:  Chanchal Gera; Navneet Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-04-28

2.  Magnetization transfer ratio in neuro-Behçet disease.

Authors:  Yonca Anik; Zekiye Kural; Ali Demirci; Gür Akansel; Sibel Aksu; Metin Vural
Journal:  Neuroradiology       Date:  2005-01-20       Impact factor: 2.804

Review 3.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

4.  Behcet's disease presenting as new onset of confusion in a male patient of North African origin in the UK.

Authors:  Ross Dolan; Suzanne Watson; Debbie Bathgate
Journal:  BMJ Case Rep       Date:  2010-12-20

5.  The seroprevalence of varicella zoster antibodies in Behçet's and other skin diseases.

Authors:  Sedat Akdeniz; Mehmet Harman; Selahattin Atmaca; Nezahat Akpolat
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

6.  Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system.

Authors:  Hae Min Kang; Sung Chul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-07       Impact factor: 3.117

7.  Urgent Surgical Management of Deep Femoral Artery Aneurysm in a Patient with Pre-Vasculo-Behcet Status.

Authors:  Tetsuya Sato; Harunobu Matsumoto; Naoyuki Kimura; Homore Okamura; Koichi Adachi; Koichi Yuri; Atsushi Yamaguchi; Shigeki Yamada; Hideo Adachi
Journal:  Ann Vasc Dis       Date:  2015-05-26

8.  Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.

Authors:  Fuat Erdem; Mehmet Gündoğdu; Ilhami Kiki; Refik Ali Sari; Ahmet Kiziltunç
Journal:  Rheumatol Int       Date:  2004-07-15       Impact factor: 2.631

9.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  Genital aphthosis in Behçet's disease: is it associated with less eye involvement?

Authors:  Seyedeh Tahereh Faezi; Cheyda Chams-Davatchi; S Zahra Ghodsi; Farhad Shahram; Abdolhadi Nadji; Massoomeh Akhlaghi; Kamran Moradi; Pedram Paragomi; Golnaz Ghazizadeh Esslami; Bahar Sadeghi Abdollahi; Farimah Ashofteh; Fereydoun Davatchi
Journal:  Rheumatol Int       Date:  2014-04-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.